AC
TMCI icon

Armistice Capital’s Treace Medical Concepts TMCI Stock Holding History

Armistice Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3M Hold
6,364,000
– – 0.31% 53
2026
Q1 		$8.53M Hold
6,364,000
– – 0.15% 100
2025
Q4 		$15.6M Buy
6,364,000
+48,000
+0.8% +$208K 0.19% 82
2025
Q3 		$42.4M Buy
6,316,000
+56,000
+0.9% +$366K 0.63% 23
2025
Q2 		$36.8M Buy
6,260,000
+49,000
+0.8% +$319K 0.64% 26
2025
Q1 		$52.1M Buy
6,211,000
+2,000
+0% +$18K 0.78% 19
2024
Q4 		$46.2M Buy
6,209,000
+13,000
+0.2% +$87K 0.63% 32
2024
Q3 		$35.9M Buy
6,196,000
+836,000
+16% +$5.37M 0.57% 33
2024
Q2 		$35.6M Buy
5,360,000
+2,960,000
+123% +$23.9M 0.45% 37
2024
Q1 		$31.3M Sell
2,400,000
-456,000
-16% -$6.08M 0.42% 38
2023
Q4 		$36.4M Buy
+2,856,000
New +$28.9M 0.5% 35

Other funds holding TMCI

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital's TMCI Position: Q2 2026 in Review

Armistice Capital held its Treace Medical Concepts (TMCI) position steady in Q2 2026 at 6,364,000 shares worth $25.3M. The position accounts for 0.31% of the portfolio, ranked #53.

Armistice Capital first reported a position in TMCI in Q4 2023 and has held it in 11 quarters since. The position peaked at $52.1M in Q1 2025. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Armistice Capital held 6,364,000 shares of Treace Medical Concepts worth $25.3M as of Q2 2026.
  • Armistice Capital left its Treace Medical Concepts share count unchanged in Q2 2026.
  • Treace Medical Concepts made up 0.31% of Armistice Capital's portfolio in Q2 2026, its #53 holding.
  • Armistice Capital first reported a position in Treace Medical Concepts in Q4 2023 and has held it in 11 quarters since.
  • Armistice Capital's Treace Medical Concepts position peaked at $52.1M in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.